State Street Corp Fulcrum Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,680,229 shares of FULC stock, worth $5.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,680,229
Previous 1,041,274 61.36%
Holding current value
$5.02 Million
Previous $6.46 Million 7.08%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.18 - $9.74 $2.03 Million - $6.22 Million
638,955 Added 61.36%
1,680,229 $6 Million
Q2 2024

Aug 14, 2024
BUY
$5.98 - $9.31 $4.69 Million - $7.3 Million
784,413 Added 305.38%
1,041,274 $6.46 Million
Q1 2024

May 15, 2024
BUY
$6.7 - $12.0 $493,883 - $884,568
73,714 Added 40.25%
256,861 $2.42 Million
Q3 2023

Nov 14, 2023
SELL
$3.25 - $6.08 $74,100 - $138,624
-22,800 Reduced 11.07%
183,147 $813,000
Q2 2023

Aug 14, 2023
SELL
$2.26 - $3.8 $1.72 Million - $2.89 Million
-759,641 Reduced 78.67%
205,947 $679,000
Q1 2023

May 15, 2023
BUY
$2.83 - $13.99 $524,042 - $2.59 Million
185,174 Added 23.73%
965,588 $2.75 Million
Q4 2022

Feb 14, 2023
BUY
$5.01 - $8.35 $275,033 - $458,389
54,897 Added 7.57%
780,414 $5.68 Million
Q3 2022

Nov 15, 2022
BUY
$4.92 - $9.1 $378,106 - $699,344
76,851 Added 11.85%
725,517 $5.87 Million
Q2 2022

Aug 15, 2022
SELL
$4.2 - $24.0 $114,609 - $654,912
-27,288 Reduced 4.04%
648,666 $3.18 Million
Q1 2022

May 16, 2022
SELL
$9.96 - $23.65 $218,691 - $519,283
-21,957 Reduced 3.15%
675,954 $16 Million
Q4 2021

Feb 14, 2022
BUY
$14.0 - $28.44 $3.44 Million - $6.98 Million
245,599 Added 54.3%
697,911 $12.3 Million
Q3 2021

Nov 15, 2021
BUY
$7.28 - $30.97 $1.02 Million - $4.34 Million
140,087 Added 44.87%
452,312 $12.8 Million
Q2 2021

Aug 16, 2021
BUY
$8.09 - $12.0 $467,019 - $692,736
57,728 Added 22.68%
312,225 $3.27 Million
Q1 2021

May 17, 2021
BUY
$10.94 - $15.32 $164,625 - $230,535
15,048 Added 6.28%
254,497 $3 Million
Q4 2020

Feb 16, 2021
BUY
$7.84 - $13.4 $214,768 - $367,079
27,394 Added 12.92%
239,449 $2.8 Million
Q3 2020

Nov 10, 2020
BUY
$7.22 - $20.7 $35,789 - $102,609
4,957 Added 2.39%
212,055 $1.68 Million
Q2 2020

Aug 14, 2020
BUY
$9.11 - $22.06 $116,935 - $283,162
12,836 Added 6.61%
207,098 $3.79 Million
Q1 2020

May 11, 2020
BUY
$9.49 - $21.26 $1.84 Million - $4.13 Million
194,262 New
194,262 $2.32 Million

Others Institutions Holding FULC

# of Institutions
150
Shares Held
52.2M
Call Options Held
6.91M
Put Options Held
1.9M
View Full List

About Fulcrum Therapeutics, Inc.

FULC Quotes by TradingView
  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $156M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email